Renin inhibitors

The present invention is directed to aspartic protease inhibitors represented by the following structural formula (I), or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the aspartic protease inhibitors of Structural Formul...

Full description

Saved in:
Bibliographic Details
Main Authors CLAREMON, DAVID A, FLAHERTY, PATRICK T, YUAN, JING, SIMPSON, ROBERT D, SINGH, SURESH B, ISHCHENKO, ALEXEY V, TICE, COLIN M, XU, ZHENRONG, MCGEEHAN, GERARD, DILLARD, LAWRENCE W, BALDWIN, JOHN J, JIA, LANQI, ZHAO, WEI, CACATIAN, SALVACION
Format Patent
LanguageEnglish
Published 02.02.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to aspartic protease inhibitors represented by the following structural formula (I), or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the aspartic protease inhibitors of Structural Formula (I). Methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using these aspartic protease inhibitors are also disclosed.
Bibliography:Application Number: AU20070297729